Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.
Open Access
- 1 January 1995
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 181 (1), 307-313
- https://doi.org/10.1084/jem.181.1.307
Abstract
To determine the functional importance of Ras in transformation by Abl oncogenes, we used a genetic approach to measure the effect of impaired Ras activity on the ability of Bcr-Abl or v-Abl to transform cells. Expression of the catalytic domain of the GTPase activating protein for Ras (Gap C terminus) impaired soft agar colony formation by fibroblasts expressing v-Abl or Bcr-Abl by 70-80%. To test Ras function in a model that more closely resembles clinical diseases involving Bcr-Abl, double gene retroviruses expressing Bcr-Abl paired with the Gap C terminus or dominant negative Ras were introduced into naive mouse bone marrow cells. Transformation by Bcr-Abl was completely blocked in both situations. Coexpression of normal c-H-Ras accelerated the transforming activity of Bcr-Abl. These findings show that Ras activation is essential for the leukemogenic activity of Abl oncogenes in two distinct model systems. The results genetically define a connection between the Bcr-Abl cytoplasmic tyrosine kinase and Ras and add to the accumulating evidence that deregulation of Ras is a central event in the genesis of a number of molecularly distinct forms of human myeloid leukemia.Keywords
This publication has 33 references indexed in Scilit:
- Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.Genes & Development, 1994
- Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.The Journal of Experimental Medicine, 1994
- SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.Molecular and Cellular Biology, 1993
- Dominant negative MYC blocks transformation by ABL oncogenesCell, 1992
- The bcr-abl gene in chronic myelogenous leukaemia.1992
- ras and GAP—Who's controlling whom?Cell, 1990
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990
- Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.1989
- Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.Molecular and Cellular Biology, 1988
- RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.Proceedings of the National Academy of Sciences of the United States of America, 1987